< path d="M52.6178 31.3114L44.7476 60.6733L74.1095 68.5435L81.9797 39.1816L52.6178 31.3114Z" fill="#F9C32D"/>

Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Anchiano Therapeutics stock

Learn how to easily invest in Anchiano Therapeutics stock.

Buy Anchiano Therapeutics (ANCN) Learn more
Fact checked

Anchiano Therapeutics Ltd is a biotechnology business based in the US. Anchiano Therapeutics shares (ANCN) are listed on the NASDAQ and all prices are listed in US Dollars. Anchiano Therapeutics employs 3 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Anchiano Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ANCN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

What's in this guide?

  1. ANCN shares summary
  2. Compare share dealing platforms
  3. Is ANCN stock a buy or sell?
  4. Stock performance over time
  5. Anchiano Therapeutics's financials
  6. How volatile are ANCN shares?
  7. Does Anchiano Therapeutics pay a dividend?
  8. Other common questions

Anchiano Therapeutics stock price (NASDAQ: ANCN)

Use our graph to track the performance of ANCN stocks over time.

Anchiano Therapeutics shares at a glance

Information last updated 2021-06-13.
52-week range$0.00 - $0.00
50-day moving average $61.36
200-day moving average $34.74
Wall St. target price$1.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-5.21

Buy Anchiano Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
eToro
Finder Award
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
Go to site
More Info
SoFi Invest
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Go to site
More Info
Tastyworks
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Go to site
More Info
JPMorgan Self-Directed Investing
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Go to site
More Info
Axos Bank Self Directed Investing
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
Go to site
More Info
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Anchiano Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Anchiano Therapeutics financials

Gross profit TTM $0
Return on assets TTM -52.84%
Return on equity TTM -125.6%
Profit margin 0%
Book value $7.71
Market capitalisation $34.9 million

TTM: trailing 12 months

Anchiano Therapeutics share dividends

We're not expecting Anchiano Therapeutics to pay a dividend over the next 12 months.

Anchiano Therapeutics share price volatility

Over the last 12 months, Anchiano Therapeutics's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

ANCN.US volatility(beta: 0.96)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Anchiano Therapeutics's is 0.9598. This would suggest that Anchiano Therapeutics's shares are less volatile than average (for this exchange).

Anchiano Therapeutics overview

Anchiano Therapeutics Ltd. , a preclinical biotechnology company, discovers, develops, and commercializes small molecule anti-cancer therapeutics. It primarily develops Pan-RAS Program that identifies novel indene-based small molecules that exhibit potent and selective inhibition of activated RAS signaling regardless of isoform or mutation; and PDE10/ß-catenin program, which identifies small molecules that selectively and potently inhibit PDE10 and suppress Wnt/APC/ß-catenin signaling in preclinical models. Anchiano Therapeutics Ltd. has collaboration and license agreement with ADT Pharmaceuticals, LLC to research and develop programs related to the pan-RAS and PDE10/ß-catenin programs. The company was formerly known as BioCancell Ltd. and changed its name Anchiano Therapeutics Ltd.

  1. Technical analysis graphic from TradingView
  2. Stock prices and other date from EOD Historical Data

Frequently asked questions

What percentage of Anchiano Therapeutics is owned by insiders or institutions?
Currently 3.817% of Anchiano Therapeutics shares are held by insiders and 3.455% by institutions.
How many people work for Anchiano Therapeutics?
Latest data suggests 3 work at Anchiano Therapeutics.
When does the fiscal year end for Anchiano Therapeutics?
Anchiano Therapeutics's fiscal year ends in December.
Where is Anchiano Therapeutics based?
Anchiano Therapeutics's address is: One Kendall Square, Cambridge, MA, United States, 02139
What is Anchiano Therapeutics's ISIN number?
Anchiano Therapeutics's international securities identification number is: US03280X1028
What is Anchiano Therapeutics's CUSIP number?
Anchiano Therapeutics's Committee on Uniform Securities Identification Procedures number is: 03280X102

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site